Edwards play well outside home turf; S&N's recon unit rides high for Q4
This article was originally published in Clinica
Executive Summary
Ophthalmic company Alcon rounded off fiscal 2007 with a strong fourth quarter performance. The Swiss incorporated company's surgical business enjoyed high growth in sales for its intraocular lenses (+24.3%), cataract and vitreoretinal products (+16.1%) and devices for refractive surgery (+75.4%) Refractive revenue was boosted by a $15.1m contribution from German refractive laser company WaveLight, of which Alcon became a majority shareholder in November 2007.